Suppr超能文献

以隐匿性费城染色体易位和髓外B淋巴细胞母细胞期为首发表现的慢性髓系白血病。

Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.

作者信息

Soliman Dina S, Amer Aliaa M, Mudawi Deena, Al-Sabbagh Zafar, Alkuwari Einas, Al-Sabbagh Ahmad, Ibrahim Feryal, Yassin Mohamed A

机构信息

Department of Laboratory Medicine and Pathology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha,Qatar.

Department of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

出版信息

Acta Biomed. 2018 Apr 3;89(3-S):38-44. doi: 10.23750/abm.v89i3-S.7219.

Abstract

Chronic Myeloid Leukemia (CML) is a clonal myeloproliferative neoplasm (MPN) characterized by the presence of a reciprocal translocation between the long arms of chromosomes 9 and 22, t(9;22)(q34:q11), resulting in fusion of the break point cluster region (BCR) with the ABL gene, which forms an oncogene, the transcript of which is an oncoprotein with a tyrosine kinase function. In the great majority of CML; BCR/ABL1 is cytogenetically visualized as t(9;22); giving rise to the Ph chromosome, harboring the chimeric gene. Cryptic or masked translocations occur in 2-10% patients with no evidence for the BCR/ABL rearrangement by conventional cytogenetics but are positive by Fluorescence in Situ Hybridization (FISH) and/or reverse transcriptase polymerase chain reaction (RT-PCR). These patients are described as Philadelphia negative (Ph negative) BCR/ABL1- positive CML with the chimeric gene present on the derivative chromosome 22, as in most CML cases, or alternatively on the derivative 9 in rare occasions. In the majority of cases, CML is diagnosed in the chronic phase; it is less frequently diagnosed in accelerated crises, and occasionally, its initial presentation is as acute leukemia. The prevalence of extramedullary blast phase (BP) has been reported to be 7-17% in patients with BP. Surprisingly, no extra-medullary blast crises of B- lymphoid lineage have been reported before among cases of CML as the initial presentation. We report an adult male diagnosed as CML- chronic phase when he was shortly presented with treatment-naive extramedullary B-lymphoid blast crises involving multiple lymph nodes, with no features of acceleration or blast crises in the peripheral blood (PB) and bone marrow (BM). In addition the patient had variant/cryptic Philadelphia translocation. This is the first report of CML, on the best of our knowledge, with extramedullary B-lymphoid blast phase, as initial presentation, that showed a cryptic Ph translocation.

摘要

慢性髓性白血病(CML)是一种克隆性骨髓增殖性肿瘤(MPN),其特征是9号和22号染色体长臂之间存在相互易位,即t(9;22)(q34:q11),导致断裂点簇区域(BCR)与ABL基因融合,形成一个癌基因,其转录产物是一种具有酪氨酸激酶功能的癌蛋白。在绝大多数慢性髓性白血病中,BCR/ABL1在细胞遗传学上表现为t(9;22),产生携带嵌合基因的费城染色体(Ph染色体)。隐匿性或隐蔽性易位发生在2%-10%的患者中,这些患者通过传统细胞遗传学检查没有BCR/ABL重排的证据,但通过荧光原位杂交(FISH)和/或逆转录聚合酶链反应(RT-PCR)呈阳性。这些患者被描述为费城阴性(Ph阴性)BCR/ABL1阳性慢性髓性白血病,嵌合基因存在于衍生的22号染色体上,如同大多数慢性髓性白血病病例一样,或者在极少数情况下存在于衍生的9号染色体上。在大多数情况下,慢性髓性白血病在慢性期被诊断出来;在加速期危机中诊断较少,偶尔其最初表现为急性白血病。据报道,髓外原始细胞期(BP)患者中髓外原始细胞期的患病率为7%-17%。令人惊讶的是,之前在慢性髓性白血病病例中作为初始表现的情况下,尚未报道过B淋巴细胞系的髓外原始细胞危机。我们报告了一名成年男性,在初诊时被诊断为慢性髓性白血病慢性期,当时他出现了未经治疗的累及多个淋巴结的髓外B淋巴细胞原始细胞危机,外周血(PB)和骨髓(BM)中没有加速期或原始细胞危机的特征。此外,该患者有变异/隐匿性费城易位。据我们所知,这是首例以髓外B淋巴细胞原始细胞期作为初始表现且显示隐匿性Ph易位的慢性髓性白血病报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db19/6179102/a41363d7cd88/ACTA-89-38-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验